Lupin shares opened 1% above on 6 October after the company announced receiving tentative approval from USFDA ( the United States Food and Drug Administration)....
Lupin shares hit a 52-week high of Rs 1,184.70 on 29 September after the company received an Establishment Inspection Report for its Nagpur unit-I manufacturing...
Lupin received approval from the US Food and Drug Administration for manufacturing and marketing Turqoz, a genetic equivalent of the pregnancy prevention pill Lo/Ovral-28. The...
Global pharma major Lupin Limited has received tentative approval from the US Food and Drug Administration for its new drug application for Dolutegravir Lamivudine and...